Background
A leading independent biopharmaceutical company launched an innovative product in the Dry-eye Disease (DED) space. To ensure early access to patients, the client offered a Pharmacist Savings Offer at launch in which commercial patients waiting on a coverage determination could access the medication at a substantially reduced cost. The company recognized the need for a seamless transition from the current Savings Offer to a comprehensive Patient Support Program (PSP) with innovative elements while continuing to grow and expand its market footprint.